Allergan to Divest Brazikumab, Zenpep to Close AbbVie Merger
Allergan (AGN) to divest autoimmune candidate, brazikumab and drug Zenpep in connection with its pending merger with AbbVie.
Allergan to Divest Brazikumab, Zenpep to Close AbbVie Merger
Allergan (AGN) to divest autoimmune candidate, brazikumab and drug Zenpep in connection with its pending merger with AbbVie.